Bioxcel Therapeutics, Inc. · NASDAQ:BTAI

Steinhart Richard I exercised options for 35 Bioxcel Therapeutics, Inc. shares (Form 4)

Traded Jun 15, 2026 · Filed Jun 17, 2026

On Jun 15, 2026, Steinhart Richard I (Chief Financial Officer) exercised options for 35 Bioxcel Therapeutics, Inc. shares, leaving 26,335 shares. Filed Jun 17, 2026 (Form 4).

Options exercised
35 shares
Holding after
26,335 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 15, 2026Common StockOption exercise3526,335Direct

Source

View original at SEC

Related